Trials / Completed
CompletedNCT01962155
Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters
Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,841 (actual)
- Sponsor
- Peking University First Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of our prospective study is to construct and validate a non-invasive model consisting biochemical markers, FibroScan, and radiological parameters for evaluating liver fibrosis caused by hepatitis B virus in mainland China.
Detailed description
Up to Oct, 2015,total of 1800 patients with chronic HBV infection were enrolled. Paired blood and liver biopsy samples were collected. Blood samples stored at -80 degree Celsius. Liver biopsy samples were judged by three pathology experts.
Conditions
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2015-12-01
- Completion
- 2016-09-01
- First posted
- 2013-10-14
- Last updated
- 2016-09-09
Locations
30 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01962155. Inclusion in this directory is not an endorsement.